Black Americans still suffer worse health: Why there's so little progress
One morning in late April, a small brick health clinic along the Thurgood Marshall Highway bustled with patients.
Nov 5, 2024
0
12
Hemic and Lymphatic Diseases: News and Research on Lymphoma, Non-Hodgkin
MeSH tree: C15.604.515.569.480
New immunotherapy shows complete responses in mantle cell lymphoma
Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial.
Oct 7, 2024
0
72
Diagnostic guidelines don't catch all rare cancers, study finds
Current diagnostic guidelines for a rare type of lymphoma miss a subset of patients with the disease, according to a Northwestern Medicine study published in the journal Blood.
Sep 23, 2024
0
26
Understanding athletes with lymphoma
One July evening, Allison Rosenthal, D.O., received a flurry of texts with exclamations like, "Yo, my doctor friend is famous!"
Sep 9, 2024
0
16
Breast cancer rises among Asian American and Pacific Islander women
About 11,000 Asian American and Pacific Islander women were diagnosed with breast cancer in 2021 and about 1,500 died. The latest federal data shows the rate of new breast cancer diagnoses in Asian American and Pacific Islander ...
Sep 9, 2024
0
30
Understanding CAR-T cell therapy for cancer: Researcher explains how it works
For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T ...
Sep 3, 2024
0
47
FDA approves CAR T cell treatment for resistant mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatment appears to be successful, the cancer often returns and is difficult to cure.
Aug 2, 2024
0
54
Cancer risk from pesticides comparable to smoking in some cases, study finds
In modern day agriculture, pesticides are essential to ensure high enough crop yields and food security. These chemicals, however, can adversely affect plant and animal life as well as the people exposed to them.
Jul 25, 2024
0
133
FDA-mandated CAR-T monitoring period could be halved, say researchers
In patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor (CAR)-T therapy toxicities are extremely rare after two weeks, supporting a shorter, more flexible toxicity ...
Jul 24, 2024
0
35
Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on the surface of T cells, ...
Jul 22, 2024
0
49
